Goldman Sachs’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$330M Buy
1,905,894
+926,389
+95% +$190M 0.04% 471
2025
Q4
$251M Buy
979,505
+52,102
+6% +$13.7M 0.03% 542
2025
Q3
$241M Buy
927,403
+271,616
+41% +$71.4M 0.03% 533
2025
Q2
$160M Buy
655,787
+60,951
+10% +$15.2M 0.02% 646
2025
Q1
$157M Sell
594,836
-199,517
-25% -$54M 0.03% 597
2024
Q4
$202M Sell
794,353
-96,945
-11% -$26M 0.03% 498
2024
Q3
$282M Sell
891,298
-68,441
-7% -$24.4M 0.05% 409
2024
Q2
$359M Buy
959,739
+340,039
+55% +$115M 0.06% 317
2024
Q1
$215M Sell
619,700
-164,408
-21% -$62.3M 0.04% 464
2023
Q4
$359M Sell
784,108
-97,766
-11% -$48.2M 0.07% 307
2023
Q3
$429M Buy
881,874
+48,546
+6% +$22.8M 0.09% 203
2023
Q2
$373M Sell
833,328
-27,242
-3% -$13.7M 0.08% 230
2023
Q1
$418M Sell
860,570
-274,615
-24% -$136M 0.1% 201
2022
Q4
$581M Sell
1,135,185
-157,250
-12% -$82.6M 0.14% 125
2022
Q3
$627M Buy
1,292,435
+231,760
+22% +$113M 0.16% 105
2022
Q2
$496M Buy
1,060,675
+149,420
+16% +$66.5M 0.12% 127
2022
Q1
$397M Buy
911,255
+220,532
+32% +$92.3M 0.08% 221
2021
Q4
$320M Buy
690,723
+30,714
+5% +$13.6M 0.06% 307
2021
Q3
$257M Sell
660,009
-18,015
-3% -$7.65M 0.05% 339
2021
Q2
$300M Sell
678,024
-61,496
-8% -$26.9M 0.07% 271
2021
Q1
$310M Sell
739,520
-184,623
-20% -$73.7M 0.08% 236
2020
Q4
$379M Sell
924,143
-263,976
-22% -$110M 0.1% 188
2020
Q3
$492M Sell
1,188,119
-25,915
-2% -$10.4M 0.14% 131
2020
Q2
$471M Sell
1,214,034
-77,993
-6% -$29.2M 0.14% 129
2020
Q1
$406M Sell
1,292,027
-265,022
-17% -$89.4M 0.14% 133
2019
Q4
$571M Buy
1,557,049
+481,218
+45% +$153M 0.15% 124
2019
Q3
$275M Buy
1,075,831
+4,477
+0.4% +$1.26M 0.08% 267
2019
Q2
$284M Sell
1,071,354
-607,881
-36% -$154M 0.08% 242
2019
Q1
$447M Buy
1,679,235
+22,633
+1% +$6.52M 0.13% 131
2018
Q4
$475M Buy
1,656,602
+288,999
+21% +$91.6M 0.15% 105
2018
Q3
$463M Sell
1,367,603
-111,975
-8% -$36.4M 0.12% 156
2018
Q2
$440M Sell
1,479,578
-878,920
-37% -$257M 0.12% 156
2018
Q1
$634M Buy
2,358,498
+179,113
+8% +$48.5M 0.16% 106
2017
Q4
$541M Buy
2,179,385
+327,143
+18% +$80.8M 0.13% 144
2017
Q3
$451M Sell
1,852,242
-686,999
-27% -$168M 0.11% 162
2017
Q2
$611M Sell
2,539,241
-1,943,630
-43% -$440M 0.16% 102
2017
Q1
$924M Buy
4,482,871
+2,982,781
+199% +$617M 0.25% 55
2016
Q4
$306M Buy
1,500,090
+163,240
+12% +$31.1M 0.09% 220
2016
Q3
$236M Buy
1,336,850
+128,885
+11% +$22.4M 0.07% 285
2016
Q2
$217M Buy
1,207,965
+403,385
+50% +$71.7M 0.07% 314
2016
Q1
$147M Sell
804,580
-208,002
-21% -$36.1M 0.05% 468
2015
Q4
$181M Buy
1,012,582
+550,957
+119% +$96.7M 0.06% 389
2015
Q3
$82.6M Sell
461,625
-142,728
-24% -$26.4M 0.03% 732
2015
Q2
$116M Sell
604,353
-244,052
-29% -$45.3M 0.04% 568
2015
Q1
$151M Buy
848,405
+318,962
+60% +$50.5M 0.05% 467
2014
Q4
$76M Sell
529,443
-179,184
-25% -$24.5M 0.02% 829
2014
Q3
$92.3M Sell
708,627
-317,936
-31% -$40.4M 0.03% 675
2014
Q2
$131M Sell
1,026,563
-1,793,018
-64% -$212M 0.04% 540
2014
Q1
$318M Sell
2,819,581
-104,025
-4% -$10.8M 0.1% 189
2013
Q4
$302M Sell
2,923,606
-412,115
-12% -$40.4M 0.1% 211
2013
Q3
$311M Buy
3,335,721
+552,956
+20% +$50.7M 0.12% 170
2013
Q2
$235M Buy
+2,782,765
New +$220M 0.09% 221

Other funds holding HUM

Goldman Sachs's HUM Position: Q1 2026 in Review

Goldman Sachs increased its Humana (HUM) stake by 95% in Q1 2026, buying an estimated $190M and bringing the position to 1,905,894 shares worth $330M. The position accounts for 0.04% of the portfolio, ranked #471.

Goldman Sachs first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $924M in Q1 2017. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Goldman Sachs held 1,905,894 shares of Humana worth $330M as of Q1 2026.
  • Goldman Sachs bought 926,389 Humana shares in Q1 2026, an estimated $190M.
  • Humana made up 0.04% of Goldman Sachs's portfolio in Q1 2026, its #471 holding.
  • Goldman Sachs first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Humana position peaked at $924M in Q1 2017.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.